AK Medical Holdings (HKG:1789) expects a 50% increase in its net profit attributable to the shareholders for 2024, compared with 182.1 million yuan for the corresponding period of the previous year, according to a Sunday filing with the Hong Kong Bourse.
The company attributed the profit increase to a higher demand for surgical products and stable operational costs, aided by effective cost control measures and national procurement policies.
The orthopedic products business plans to publish its annual results by the end of March.
The company's shares were up over 15% in the recent trading.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.